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Abstract
We studied hue discrimination and brightness matching throughout the spectrum in ten juvenile patients suffering from diabetes
mellitus (Type I) with no (eight patients) or mild (two patients) retinopathy. In addition, the FM 100-Hue test was performed.
The data were collected once every year over 5 years. Over the 5 years, the diabetics show a continual change in the shape of their
brightness matching function. Wavelength discrimination ability remains quite stable with time at the long end of the spectrum
but is variable at short wavelengths. FM-100 error scores remain similar over the period tested, at a level slightly higher than that
of a control group. Additional experiments show that the sensitivity of the S-cone in the diabetic group is similar to that of
controls. The results can be explained by an early relative reduction in the sensitivity of post-receptoral processes in juvenile
diabetics. © 1999 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Elevated blood glucose levels in patients suffering
from diabetes lead to retinal vascular changes, anoxia
and cell death. The development of a retinopathy de-
notes that the vascular changes are clinically apparent
in the retina, but changes in the metabolism of the
diabetic eye occur before an alteration of the fundus
(Cunha-Vaz, Faria de Abreu, Campos & Figo, 1975;
Greene, Lattimer & Sima, 1987; Tehrani, Yamamoto &
Garner, 1990; Gonzalez Flecha, Bermudez, Ce´dola,
Gagliardino & Rossi, 1990). Anoxia and decreased
metabolic activity cause changes in the membrane equi-
librium potential, producing a scaling down of the
response of retinal cells and can depress the visual
system’s sensitivity to light (Greenstein, Hood & Camp-
bell, 1982; Hood & Greenstein, 1982). This can be seen
in dark-adaptation measurements in some diabetics
with and without visible retinopathy, who have been
shown to have higher thresholds than normal or take
longer to adapt (Henson & North, 1979). But the most
widely reported early visual deficits in diabetics are
those of the Tritan type, involving a loss in sensitivity
at the short wavelength end of the spectrum as mea-
sured by hue discrimination or spectral thresholds (Kin-
near, Aspinall & Lakowski, 1972; Marre´ & Marre´,
1972; Lakowski, Aspinall & Kinnear, 1972:1973; Zwas,
Wiess & McKinnon, 1980; Zisman & Adams, 1982;
Greene, Ghafour & Allan, 1985; Roy, Gunkel &
Podgor, 1986; Trick, Burde, Gordon, Santiago & Kilo,
1988; Peduzzi, Longanesi, Ascari, Cascione, Galletti,
Roncaia, Pacchioni & Maione, 1989; Greenstein,
Sarter, Hood, Noble & Carr, 1990; Kurtenbach, Wag-
ner, Neu, Schiefer, Ranke & Zrenner, 1994; Kurten-
bach, Ru¨ttiger, Schiefer, Zrenner & Neu, 1995). In
considering the short wavelength deficit, it has been
stressed by several authors that the different response
ranges of the cones, along with differential adaptation
can make the S-pathway appear more vulnerable to
retinal disease (Hood, Benimoff & Greenstein, 1984;
Greenstein, Hood, Ritch, Steinberger & Carr, 1989;
Kalloniatis & Harwerth, 1989, 1990; Greenstein,
Shapiro, Zaidi & Hood, 1992).
The sensitivity loss may be caused by changes at
several sites. At the preretinal level diabetics show an
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accelerated yellowing of the lens (Lutze & Bresnick,
1991), which causes a filtering of short wavelength light.
Retinal function is also impaired. A priori, one may
expect early changes of inner retina function, due to a
disturbance of retinal circulation. Indeed the opponent
system between the short (S) and long and middle
wavelength sensitive cones (LM) has been shown to
manifest early changes in sensitivity in patients with
retinopathy, at or beyond the inner retinal sites of
chromatic opponency (Schefrin, Adams & Werner,
1991; Greenstein, Shapiro, Zaidi & Hood, 1992). These
studies ruled out a receptor contribution to the deficit.
On the other hand, reduced diffusion of oxygen from
the outer retina to supply ischemic inner retinal layers,
could cause receptor malfunction (Flower & Patz,
1971). Elsner, Burns, Lobes & Doft (1987) have found
abnormalities in the photopigment bleaching of long
(L) and middle (M) wavelength sensitive cones in some
diabetics with and without retinopathy. Short wave-
length sensitive cones were not tested.
The study of diabetic patients is complicated by a
considerable interindividual variability. Blood sugar
level and duration of disease are important factors for
the development of a retinopathy, but in many cases
there is no significant correlation between them
(Lakowski, Aspinall & Kinnear, 1972:1973; Greenstein,
Sarter, Hood, Noble & Carr, 1990). Similarly, decreases
in sensitivity in most reports are not significantly corre-
lated to the degree of retinopathy. Results may be
confounded by the blood glucose level at the time of
testing, which have recently been shown to cause a
transient decrease in S-pathway sensitivity (Volbrecht,
Schneck, Adams, Linfoot & Ai, 1994) and contrast
sensitivity in some patients (Mangouritsas, Katoulis,
Kepaptsoglou & Zoupas, 1995). Recent results using
the desaturated D-15 panel test (North, Cooney, Cham-
bers, Dolbern & Owens, 1997), on the other hand, show
no correlation between increases in plasma glucose and
colour vision in diabetics. Despite this variability be-
tween individuals, high blood sugar levels and a long
duration of diabetes are most likely to lead to sensitiv-
ity and fundus changes.
The purpose of this experiment was to study the
development of the early sensitivity and colour deficit
in diabetics. We have reported the initial results for 20
juvenile patients (Kurtenbach, Wagner, Neu, Schiefer,
Ranke & Zrenner, 1994). For ten of these patients we
monitored the average results in a yearly examination
over a 5 year period. The remaining ten patients either
did not wish to continue in the study or had moved
from the area. Juveniles seldom show signs of vascular
alteration before puberty, and so this period of hor-
mone change reflects a critical time in the development
of a retinopathy (Lakowski, Aspinall & Kinnear, 1972:
1973; Klein, Klein & Moss, 1989). Each year the sub-
jects underwent an ophthalmological examination and
we tested pyschophysically, brightness matching and
wavelength discrimination throughout the spectrum, as
well as administering the Farnsworth–Munsell 100-Hue
Test (FM-100), a clinical panel test of hue discrimina-
tion. The results obtained after 1 year in 20 subjects
(Kurtenbach, Wagner, Neu, Schiefer, Ranke & Zren-
ner, 1994) and after 3 years in ten patients (Kurten-
bach, Ru¨ttiger, Schiefer, Zrenner & Neu, 1995) showed
changes in brightness and colour perception. The re-
sults to be reported here show that the most prominent
changes after 5 years are to be found in the perception
of brightness.
2. Method
2.1. Subjects
Ten insulin dependent volunteers, suffering from dia-
betes mellitus (Type I) were studied. They were aged
between 11 and 18 years (mean 91 SD: 14.3492.24;
median 14.3) at the first year of testing and had had
diabetes for between 4 and 12 years (mean 7.9193.26;
median 7.2). They were recruited from the Children’s
Hospital, Tu¨bingen which they had attended on aver-
age every 8–10 weeks since the onset of the disease for
control examinations. The metabolic values used in this
study were taken within 94 weeks of the psychophysi-
cal testing. The average yearly values for creatinine,
b2-microglobulin and urea remained below population
recommended values, those for cholesterin and triglyce-
ride varied around the upper population limit. Only the
average blood glucose level (measured by glycosylated
haemoglobin, gHb) was raised above the normal limit.
Over the 5 years, this average value dropped from
11.38% (93.16; median 9.6) in the first year of testing
to 9.57% (91.46; median 9.31) in the last, and varied
between 7.5 and an unusually extreme value of 18%.
Eight of the subjects showed no signs of vascular
changes in the retina. The two oldest subjects, who had
had diabetes for over 12 and 9 years, both showed signs
of a few microaneurisms (Bresnick stage 2) at the start
of the experiment. Over the period tested, the number
of microaneurisms sporadically changed, but the
retinopathy remained at this stage of development.
Lens changes were not detectable with slit lamp exami-
nation, and visual acuity and intraocular pressure were
normal.
The colour vision of the diabetic group (ten patients
in years 1, 3, and 5; nine patients in years 2 and 4), was
compared to those of a control group of 20 healthy
subjects aged between 11 and 22 years (mean 17.89
3.3). They were admitted to the study if their colour
vision, as tested with the FM-100 test, and visual acuity
were normal. Fundus examination or photography was
not carried out. The full control group was tested in the
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first year only. At the end of the 4th year, six of them
were retested.
2.2. Method and procedure
Subjects first underwent an ophthalmological exami-
nation with visual acuity measurements and then per-
formed the psychophysical tests, outlined below.
Finally intraocular pressure was measured and the fun-
dus was examined (direct and indirect ophthalmoscopy)
and photographed.
The psychophysical tests, which were performed
monocularly, consisted of the FM-100, measured under
standardised procedures (colour temperature 6000 K;
1500 lux), heterochromatic brightness matching (HBM)
and wavelength discrimination. The latter two were
performed using a computer driven three channel
Maxwellian view system (Reitner, Sharpe & Zrenner,
1992). Subjects monocularly viewed a 2° circular bipar-
tite field, separated by a 5 min arc black line. Their
head was held steady with a chin and head rest. The
subjects were instructed to match in brightness each
wavelength presented in the left hemifield, with a 540
nm, 8.5 log Q:s per deg2 (260 td) reference hemifield
presented to the right hemifield. Brightness matching
was measured in 10 nm steps from 420 to 680 nm. An
ascending and descending method of limits was used,
and the mean of 4 measurements calculated for each
data point. An equally bright homogeneous adaptation
field (6000 K) was presented for 20 s between each
wavelength presentation, to maintain a uniform adapta-
tion level. These equal brightness matches were then
used for the subsequent wavelength discrimination ex-
periment performed between 440 and 640 nm in steps
of 20 nm, carried out without further readjustment for
equal brightness. The bipartite field was presented for 1
s between an adaptation field presentation of 5 s, after
which the subject indicated whether he had perceived a
difference in hue between the two hemifields. Wave-
length was varied in 1 nm steps. An ascending method
of limits was used to find the just noticeable difference
(delta lambda) for main wavelengths. Five measure-
ments were taken: the first was discarded and the mean
of the remaining four used to determine each data
point. One experimental session lasted on average
about 2 h.
3. Results
In Fig. 1, we have plotted the results of heterochro-
matic brightness matching to a standard of 540 nm, 260
td. Log relative sensitivity, calculated from the inverse
of the matched luminance, is plotted against the wave-
length. The curves have been displaced on the Y-axis
for clarity. The uppermost curve shows the mean re-
sults of the control group of 20 subjects in the first year
of testing. The hairline shows the mean results of the
six subjects repeated after 4 years. The open circles
show the mean results obtained from the diabetic group
for each year of testing. Over the years, the HBM curve
in the diabetic group alters its shape. The curve be-
comes shallower, extending around 1.3 log units in
depth for the first year of testing, and 1.1 log unit in the
5th year. The average standard errors (see Fig. 4) are
around 0.1 log unit, showing that the shape of curve
differs considerably between individual subjects. The
average standard deviation within the results of one
subject, however, was around 0.05 log units. There was
no significant correlation between the gHb levels and
the sensitivity at 570 or 460 nm (least squares linear
regression).
Fig. 1. Results for heterochromatic brightness matching against a
standard of 540 nm and 260 td. Log relative-sensitivity (reciprocal of
the matched luminance) is plotted against wavelength. The curve for
the control group for the first year of testing (filled squares) and the
repeat (hairline) both show an inverted U-shaped function. The
results from the diabetic group are shown by open symbols () for
years 1–5. Curves are displaced for clarity on the Y-axis.
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Fig. 2. The just noticeable difference in wavelength (delta lambda)
plotted against wavelength for the control group (91 SE) compared
to the yearly averages for the diabetic groups (filled symbols). Mean
values obtained from six subjects from the control group repeated in
year 4 are shown by the hairline.
delta lambda values at 440 and 460 nm (paired t-test).
There was also no significant correlation between gHb
and the delta lambda value at 460 nm.
The results of the FM-100 panel test (1 SD) can be
seen in Fig. 3, for the control and the diabetic groups
over the 5 years. Because the distribution of error
scores is skewed, the square root of the error score is
shown, which follows a normal distribution (Kinnear,
1970).
The total error score (upper panel) has been divided
into two groups representing the errors in the red-green
quadrants (caps 14–34, 56–76, middle panel) and the
blue-yellow quadrants (caps 1–13, 35–55, 77–85, lower
panel) of the colour circle. It is notable that the first
year of testing, for both groups, yielded substantially
higher scores than the subsequent years. All mean
diabetic total scores are below the normal limit for this
age group. In the first year of testing their results are
higher than those of the control group and in the 4
Fig. 3. The square root of mean error scored (1 SE) obtained by
the control and diabetic groups in the FM-100 Test. Upper panel:
total score. Middle panel: R-G score. Lower panel: B-Y score.
The results we obtained from the wavelength discrim-
ination task can be seen in Fig. 2, where the just
noticeable difference in wavelength (delta lambda) is
plotted against the wavelength for each year of testing.
The results from the control group are shown by the
continuous thick line (91 SE). The repeat control
group of six subjects is again shown by the hairline. At
the extreme ends of the spectrum, the values deviate
somewhat from the original results. For the diabetic
group, the results over the 5 years show some variabil-
ity. The first year shows in general a higher delta
lambda, except in the short wavelength spectral region.
For the following years, the curve, at least in the long
wavelength region, returns to near control level. At the
short wavelength end of the spectrum, the results are
much more variable. In the second and third years,
there is a pronounced, though not significant rise in
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subsequent years their results remain relatively con-
stant, but with more errors than the repeat control
group. In the first year of testing, the B:Y scores of the
diabetics are significantly different from those of the
controls (PB0.05, unpaired t-test). There is no signifi-
cant correlation between the FM-100 scores and gHb
levels (least squares linear regression).
4. Discussion
4.1. Heterochromatic Brightness Matching
The HBM results (Fig. 1) show progressive changes
in sensitivity over the 5 years in the diabetic group.
HBM curves, unlike spectral threshold measurements,
give no information about the absolute sensitivity, i. e.
how bright or dark the comparison field appears for
individual subjects, and all curves necessarily come
together here at 540 nm, the comparison wavelength.
The diabetic curves thus show a relative increased
sensitivity at short and long wavelengths in comparison
to the control curve. To try to characterise the changes
seen in the diabetic groups, we first compare our results
to the CIE (1978) HBM function for the standard
observer. In Fig. 4 (upper panel), we show the mean
results for our control group (91 SE) in comparison to
the CIE function (thick continuous line). The hairline
shows the mean values for the six control subjects
repeated in year 4. To gain information about absolute
sensitivity, we slid the experimental curve along the
Y-axis to obtain maximum overlap with the HBM
function, the assumptions being that the curves are thus
optimally positioned, and that the most sensitive mech-
anism responds and will dominate in the curves (Lee &
Martin, 1989; Sperling, 1993). The control data points
found in this experiment lie very close to the CIE
function, except in the region around 540 nm, the
wavelength of the comparison field. The lower panel in
Fig. 4 shows the mean results of the juvenile diabetic
group for years 1, 3 and 5 in comparison to the CIE
function. Using this method of presentation, the dia-
betic group show a decrease in sensitivity between 500
and 600 nm for year 1, spreading to between 440 and
630 nm for year 5. It is thus probable that the juvenile
diabetics exhibit a relative reduction of sensitivity at
middle wavelengths, compared to short and long
wavelengths.
The shape of the HBM function is thought to be
determined by opponent colour mechanisms, formed by
the subtractive interaction of cone responses, as well as
the non-opponent achromatic channel (Guth & Lodge,
1973; Ingling & Tsou, 1977; Yaguchi & Ikeda, 1982;
Nakano, Ikeda & Kaiser, 1988; Kalloniatis & Pianta,
1997). We used the Smith & Pokorny (1975) cone
fundamentals to calculate opponent functions. Interac-
Fig. 4. Results obtained in this study compared to CIE (1978)
brightness matching function for the standard observer (thick contin-
uous line). Bars denote 91 SE. Upper panel: control groups: year
1(filled symbols) and repeat (hairline). Lower panel: diabetic groups
year 11 SE (), year 3 () and year 5, 1 SE (*).
tion coefficients were the mean of those calculated by
Nakano, Ikeda & Kaiser (1988) from the brightness
matching results of ten subjects, i.e.
L-M opponency1.35 log L0.35 log M
M-L opponency1.93 log M0.93 log L
The opponent pathways thus calculated can be seen
compared to our control results in the upper panel of
Fig. 5 (continuous lines). Individual mechanisms were
again shifted on the Y-axis to provide maximum over-
lap. Together they provide a reasonable fit to our
control curve for most of the spectrum. Sensitivity at
the short wavelength end of the spectrum is low. This is
due to the relatively low luminance (260 td) used in this
experiment: the long and middle wavelength sensitive
pathways will be more sensitive to luminance changes
than the short wavelength sensitive pathway (Sperling
& Harwerth, 1971; Yeh, Smith & Pokorny, 1989;
Kalloniatis & Harwerth, 1990). For comparison pur-
poses only, we have indicated the sensitivity of the
S-cone mechanism and of the non-opponent channel
(calculated following Kalloniatis & Pianta, 1997; L
2.72 M), with discontinuous lines in Fig. 5.
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In the lower panel of Fig. 5, we have plotted the
diabetic results in the last year of testing, compared to
these opponent and non-opponent functions and the
short wavelength cone mechanism. The results of the
juvenile diabetics can be explained by a relative reduc-
tion either in the sensitivity of the opponent M-L
pathway or the non-opponent channel, or both. At the
short wavelength end of the spectrum, the S-cone mech-
anism appears to be more prominent in the diabetic
curve compared to the control results.
To study further the sensitivity changes at the short
end of the spectrum, we performed one additional
experiment, year 6 after the start of the study. Here we
reduced the purity of the stimulus to 0.26 by superim-
position of a bright white background field. This proce-
dure, at least in the spectral region between 540 and 600
nm, produces HBM curves very similar to threshold
spectral sensitivity curves, with pronounced opponent
mechanisms, most probably due to adaptation of the
non-opponent pathway (Kurtenbach, Ru¨ttiger, Kaiser
& Zrenner, 1997). Brightness matching was made in
this case against a white comparison hemifield of 260
td. The mean results can be seen in Fig. 6, where the
results from the same diabetic group (open symbols)
Fig. 6. HBM functions obtained with a desaturated stimulus found in
the diabetic group (open circles; 1 SE) compared with those from
an age matched control group (filled squares; 1 SE). Continuous
lines model opponent functions and the discontinuous line, the sensi-
tivity of the S-cone (see text for details).
are compared to those from a new age-matched control
group of ten subjects (solid symbols), aged between 16
and 25 (mean 19.0693.16). Error bars indicate 91
SE. The continuous lines depict opponent mechanisms,
here based on spectral sensitivity threshold measure-
ments. The peaks of the spectral sensitivities of the cone
fundamentals (Smith & Pokorny, 1975) were nor-
malised to 1 on an energy basis at the cornea. We then
used an interaction factor of 1.35, the average found for
five observers by Calkins, Thornton & Pugh (1992) to
calculate the antagonistic processes, i.e.:
SLML1.35 M
SML1.35 ML
At the short wavelength end of the spectrum, we
again show the S-cone sensitivity with a discontinuous
line. The results are quite similar with no significant
differences, although the diabetics are slightly lower in
sensitivity for both opponent mechanisms. As with
threshold spectral sensitivity measurements, this
method gives data points at the short wavelength end of
the spectrum that are well-fit by the sensitivity of the
S-cone.
The data points from the diabetic group in Fig. 6 are
very similar to those of the controls, indicating that the
S-cone sensitivity is unaltered in these juvenile diabet-
ics. Lutze & Bresnick (1991) have shown that diabetics
in this age group may be around 0.2 log units less
sensitive at the short wavelengths, due to premature
ageing of the lens. This may not be detected by slit-
lamp ophthalmoscopy used in this study to assess the
lens opacity, but the similarity of the curves at the short
Fig. 5. Comparison of the components underlying the brightness
function (see text for details) with the results for the control group
(upper panel) and diabetic group, year 5 (lower panel).
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wavelength end of the spectrum indicate that lens
changes do not play a significant role in these results.
4.2. Wa6elength discrimination
The shape of the wavelength discrimination curve for
the control group (Fig. 2) resembles the classical dis-
crimination data of Laurens & Hamilton (1923) and
Wright & Pitt (1934). We find higher values due to the
method used. The diabetic group shows no continuous
trend over the 5 years. In the first year of testing there
is a general increase in delta lambda, which is not
stable, so that after 5 years, the curves are more similar
to those of the controls and show better discrimination
than in the first year. Two factors may contribute to an
increase in discriminability over the years: Firstly, there
may be a learning effect. Secondly, it is possible that
the discrimination ability increases with age in juve-
niles, as shown by Verriest (1963) for the FM-100 test
(see below).
The task of hue discrimination depends on opponent
interactions between receptors and is limited by the rate
of change with wavelength of the ratio of quantum
catches (L:M and S:L or S:M) and by the dynamic
range of post-receptoral channels. The shape of the
wavelength discrimination curve is most likely deter-
mined by the L:M ratio throughout the majority of the
spectrum and only the region between 460 and 520 nm
is thought to reflect the activity of the S:L (or S:M)
mechanisms (Mollon & Jordan, 1988:1989; Mollon,
Este´vez & Cavonius, 1991). Our diabetic function is
most constant at the long wavelength end of the spec-
trum indicating little change in the L:M ratio. At the
short end of the spectrum the results are much more
variable. This variability of the S-pathway sensitivity
may reflect the acute blood glucose levels at the time of
testing, which have been shown to affect the short
wavelength pathway sensitivity (Volbrecht, Schneck,
Adams, Linfoot & Ai, 1994).
4.3. Farnsworth–Munsell 100-Hue test
The FM-100 is also a test of hue discrimination. The
results (Fig. 3) show a stable error score in the diabetic
group over the years, apart from the error score ob-
tained in the first year. The control group also shows a
large decrease in error score at the second testing. This
can be explained by a learning effect: Verriest, Van
Laethem & Uvijls (1982) have reported a significant
decrease of monocular test scores on retesting with the
FM-100 for this age group. In addition, the average
FM-100 error score decreases with age until around
20–29 years (Verriest, 1963). Due to the age of our
subjects (mean 14.34 years at the start of the experi-
ment) some decrease in error score over the years may
be expected.
Diabetics with retinopathy are known to show Tritan
errors with the FM-100, as well as a reduced discrim-
inability throughout the spectrum (Birch & Dain,
1987). Our results with juvenile diabetics also show a
slightly reduced hue discriminability throughout the
spectrum, and for the first year of testing only, signifi-
cantly higher B:Y scores than the control group, al-
though the error scores are still within those of the
normal population. Similar results have previously been
reported by Roy, Gunkel & Podgor (1986) and Trick,
Burde, Gordon, Santiago & Kilo (1988). We also
confirm the tendency for a higher blue-yellow partial
error score compared to red-green score for both con-
trol and diabetic groups for this test as found by Trick,
Burde, Gordon, Santiago & Kilo (1988) and Green-
stein, Shapiro, Zaidi & Hood (1990). The reason for
this lies in the colour differences between adjacent caps:
adjacent caps in the blue quadrant show smaller colour
differences than those in other quadrants, causing it to
be more difficult (Lakowski, 1969).
5. Conclusion
The deficit we find in these juvenile patients is not
generally of the Tritan type. On the contrary, we have
shown that their S-cone sensitivity is normal (Fig. 6).
We also find no evidence for defects of either M or L
cone, which would be apparent as an relative increase
in error scores in the R–G quadrants of the FM-100
test, or larger delta lambda values at middle and long
wavelengths in the wavelength discrimination experi-
ment. The results of anomaloscope matches for a larger
group of 17 juvenile diabetics, including the ten studied
here, are in agreement with these findings (Kurtenbach,
Schiefer, Zrenner & Neu, 1997).
The deficit shown in HBM curves from juvenile
diabetics is explicable by a relative reduction in func-
tions affecting the central spectral regions, post recep-
toral opponent or non-opponent channels. Malfunction
at the postreceptoral level of the retina may also ex-
plain the reduced discrimination ability throughout the
spectrum seen in the FM-100 test error scores.
The results of both hue discrimination experiments
(FM-100 and wavelength discrimination) although dif-
fering widely in ease of accomplishment for the sub-
jects, both show better performance at year 5 than year
1, indicative of learning or age effects for both these
tasks. Volbrecht, Schneck, Adams, Linfoot & Ai (1994)
and Mangouritsas, Katoulis, Kepaptsoglou & Zoupas
(1995) have shown that increases in blood sugar level
lead to immediate transient changes in sensitivity. This
may have some influence on the wavelength discrimina-
tion and FM-100 results. But on the results of the
HBM, it can have little effect, as we find a progressive
decrease in sensitivity, despite a generally better control
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of the disease by the subjects. The changes found in the
HBM curve may thus reflect the chronic changes in the
diabetic eye.
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